Email Updates
Go to Basic Search
Results
Total Results: 2,078 records
Showing results for "drugs".
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/does-the-use-of-cytochrome-p450-2c19-cyp2c19-testing-to-predict-response-to-clopidogrel-in-people-1-with-acute-coronary-syndrome-2-who-have-suffered-other-cardiovascular-disease-related-events-eg-ischemic-stroke-symptomatic-pAugust 04, 2010 - yes If yes, explain the specific technologies, devices, drugs, or interventions you would like to
-
Abnormal-Uterine-Bleeding Executive (pdf file)
effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdfMarch 01, 2013 - Pomona, NY: Duramed Pharmaceuticals, Inc.; 2009. 83. Nordette [package insert]. … Wayne, NJ: Bayer HealthCare Pharmaceuticals, Inc.; 2012. 86. … Wayne, NJ: Bayer HealthCare Pharmaceuticals, Inc.; 2009. 92. FDA. … Morgantown, WV: Mylan Pharmaceuticals, Inc.; 2006. 106. Naprosyn [package insert]. … Nonsteroidal anti- inflammatory drugs for dysmenorrhoea. -
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/peripheral-artery-disease-pad-defined-as-peripheral-artery-disease-of-the-lower-extremities-1-does-aspirin-reduce-the-risk-of-adverse-cardiovascular-events-mi-stroke-cardiovascular-death-in-patients-with-pad-is-there-a-differJanuary 20, 2011 - yes If yes, explain the specific technologies, devices, drugs, or interventions you would like to
-
effectivehealthcare.ahrq.gov/products/skin-cancer/researchDecember 08, 2017 - Recurrence rates for SCC in situ were lower with PDT and cryotherapy than with drugs.
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-are-the-best-practice-behavioral-health-programs-for-type-1-diabetes-type-2-diabetes-and-gestational-diabetes-does-educational-counseling-help-paitients-improve-control-and-adherence-to-treatmentMay 04, 2012 - yes If yes, explain the specific technologies, devices, drugs, or interventions you would like to
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-renal-of-differnt-contrast-media-used-in-radiographic-imaging-what-is-the-comparative-efficacy-of-different-therapies-in-preventing-contrast-induced-nephropathyDecember 30, 2011 - yes If yes, explain the specific technologies, devices, drugs, or interventions you would like to
-
Appendix-F1-Surveillance-Report-1 (xls file)
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-f1-surveillance-report-1.xlsxNovember 22, 2021 - Title Appendix F - Data Abstraction of Efficacy Outcomes NPP_Pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseli… -
effectivehealthcare.ahrq.gov/products/nephropathy-contrast-induced/research-protocolNovember 12, 2013 - Recent publications have questioned the role of N- acetylcysteine (NAC), 8 withdrawal of nephrotoxic drugs … ., ACE inhibitors, angiotensin II receptor blockers, diuretics, and non-steroidal anti-inflammatory drugs … the FDA mini-sentinel site ( https://www.sentinelinitiative.org/ ) for data available on FDA approved drugs … , we will explore the FDA AERS database for reported adverse events attributed to contrast media or drugs … Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
-
Psoriasis-Chronic Executive (pdf file)
effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdfNovember 01, 2012 - patients with widespread disease.4,8,9 Biologic therapies for psoriasis use genetically engineered drugs … Comparisons of drugs within each class was beyond the scope of this report. … Please see the glossary for a listing of drugs considered within each class. … results was conducted on www.clinicaltrials.gov and associated FDA regulatory documents for these drugs … J Drugs Dermatol. 2007;6:424-427. PMID: 17668540. 12 AHRQ Pub. -
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management_research-protocol.pdfJanuary 01, 2014 - programs target Medicare Part D enrollees, who have multiple chronic diseases, are taking multiple Part D drugs … , and are likely to incur annual costs for covered Part D drugs that exceed a predetermined level (“ … A plan may require no more than eight Part D drugs, although they may set at the maximum at any number … personal medication report, which is a written list of the patient’s prescription and nonprescription drugs … Drugs. 2009;69(4):393-406. PMID: 19323584. 3. Lewin Group.
-
effectivehealthcare.ahrq.gov/products/mental-illness-adults-prisons/research-protocolSeptember 13, 2012 - a lower risk for developing movement disorders and other unpleasant side effects, but some of these drugs … in most prison formularies for treating bipolar disorder and schizoaffective disorder because these drugs … Drug therapy/ Exp antidepressive agents/ Psychotropic drugs/ Therapeutic use.fs. … OR exp neuroleptic agent/ OR exp neuroleptic drugs/ OR psychopharmacotherapy/ OR psychotropic agent/ … OR psychotropic drugs/ 8 Pharmacologic interventions Text words (drug ADJ (based
-
Template for Reports Developed (pdf file)
effectivehealthcare.ahrq.gov/sites/default/files/pdf/allergy-seasonal_research-protocol.pdfMarch 08, 2012 - Six classes of drugs and nasal saline are used to treat SAR. … Several drugs have more than one route of administration (e.g., intranasal and oral), as described below … Plasma concentrations of these drugs are increased by cytochrome P450 inhibitors, such as macrolide … Drugs that were effective before pregnancy may be effective during pregnancy, but their use may be … Drugs used to treat SAR are pregnancy category B (presumed safe based on animal studies but without -
effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdfJune 01, 2013 - In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … Drugs Today. 2010;46(1):49-67. 3. Sorbera LA, Dulsat C, Rosa E. … East Hanover (NJ): Novartis Pharmaceuticals Corporation; 2012 May. 22 p. … Drugs Future. 2010;35(2):93-7. … Also available: http://blue.regence.com/trgmedpol/drugs/dru256. pdf. 46.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsxSeptember 20, 2022 - NPP_Pain Table F-1a. Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (Wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseline Variance Grp1 Baseline Lower Limi…
-
Data-Points-9 Maps (pdf file)
effectivehealthcare.ahrq.gov/sites/default/files/data-points-9_maps.pdfMarch 29, 2012 - Utilization of Sulfonylureas per 100 Diabetic Medicare Beneficiaries With Continuous Enrollment in Parts A and B FFS and Part D, by Hospital Referral Region (HRR), 2006-2009 Annual Utilization of Sulfonylureas Among Diabetic Beneficiaries With At Least One Antidiabetic Drug Order, by HRR, 2006 Annual Util… -
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsxSeptember 20, 2022 - NPP_Pain Table F-1a. Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (Wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseline Variance Grp1 Baseline Lower Limi…
-
Gout Executive (pdf file)
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdfMarch 01, 2016 - Table A lists the drugs used to treat gout and notes the ones covered in this systematic review. … formulation Numerous Colchicine/ColcrysTM, Colchicine tablets, USP authorized generic Takeda Pharmaceuticals … None of the trials described in these information packets was included in this report, as the drugs … Non-steroidal anti-inflammatory drugs for acute gout. Cochrane Database Syst Rev. 2014;9:CD010120. … Noncompliance with arthritis drugs: magnitude, correlates, and clinical implications. -
effectivehealthcare.ahrq.gov/products/antipsychotics/research-protocolSeptember 06, 2018 - who have been diagnosed with delirium using a validated instrument Interventions: Antipsychotic drugs … , risperidone, ziprasidone) We will only include studies where the effects of the antipsychotic drugs … quetiapine, risperidone, ziprasidone) We will exclude studies where the effects of the antipsychotic drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsxSeptember 20, 2022 - NPP_Pain Table F-1a. Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (Wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseline Variance Grp1 Baseline Lower Limi…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/delirium-research-protocol.pdfJune 01, 2018 - have been diagnosed with delirium using a validated instrument • Interventions: o Antipsychotic drugs … , risperidone, ziprasidone) o We will only include studies where the effects of the antipsychotic drugs … quetiapine, risperidone, ziprasidone) • We will exclude studies where the effects of the antipsychotic drugs
SHARE:
Search the AHRQ Archive
Information and reports more than 5 years old may be found in the AHRQ Archive site.
Search Within A Specific AHRQ Site
You selected to view results for the following site:
